Acute Lung Injury Market CAGR of 4.7% from 2021 to 2028

1
Acute Lung Injury Market 
Acute Lung Injury Market Forecast to 2028 -
COVID-19 Impact and Global Analysis By Therapy
(Mechanical Ventilation, Fluid Management,
Pharmacotherapy, and Adjunctive Procedures) and
End User (Hospitals, Ambulatory Surgery Centers,
and Others) and Geography
2
Current and future Market Scenario
Acute Lung Injury Market 

• According to our new market research study on
  Acute Lung Injury Market to 2028 Global
  Analysis and Forecast by Therapy and End User,
  the market is expected to reach US 741.98
  million by 2028 from US 539.61 million in 2021.

3
Market Segments
Acute Lung Injury Market   
By Therapy Mechanical Ventilation Fluid
Management Pharmacotherapy Adjunctive Procedures
By End User Hospitals Ambulatory Surgery
Centers Others
4
Leading Players
Acute Lung Injury Market  
Company Profiles in Acute Lung Injury Market
are GlaxoSmithKline plc. Stemedica Cell
Technologies, Inc Histocell APEPTICO Forschung
und Entwicklung GmbH Windtree Therapeutics,
Inc. ReAlta Life Sciences, Inc. Apeiron Biologics
AG Qx Therapeutics, Inc. Angion Asklepion
Pharmaceuticals, LLC
5
Acute Lung Injury Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/acute-l
ung-injury-market
Thank You!

• Thank You!